Fraxel Laser Treatment in Republic of Korea: Our Best Clinics and Costs 2025

Dr. Joo-young Park, MDChief Medical Director & CEO, BIOFACE Clinic Professional ProfileBoard-certified dermatologist and anti-aging specialist with over a decade of clinical and research leadership. Dr. Park combines expertise in laser systems, injectable aesthetics, thread-lift techniques, and regenerative therapies to deliver evidence-based protocols that prioritize patient safety, comfort, and natural, lasting outcomes. A sought-after educator and consultant, he has trained hundreds of clinicians and guided protocol development for leading medical device and biotech firms.Education & TrainingDermatology Residency, Seoul National University HospitalAdvanced training in laser therapies, injectables, and anti-aging proceduresMedical Student Summer Program, Samsung Medical Center (Sungkyunkwan Univ.)KSKCS Non-invasive Cosmetic Surgery CourseKCCS Asian Lipoplasty WorkshopProfessional ExperienceFounder, CEO & Medical Director, BioFace Clinic (2018–Present)Lead all clinical operations, research initiatives, and strategic growth both domestically and internationally.QOFill Filler Educator, JW Pharmaceutical (2016–Present)Deliver hands-on workshops on safe, precise filler injection techniques to over 300 physicians nationwide.HIFU Lifting Technology Consultant (2017–Present)Advise device manufacturers on protocol optimization to maximize lift efficacy while minimizing downtime.Clinical Advisor, L&C BIO (KOSDAQ-listed) (2019–Present)Design and analyze clinical trials for novel dermatologic injectables.Clinical Advisor, UTI (Application Specialist)Provide scientific support and training for UTI’s aesthetic device portfolio.Technical Consultant, NewTheraGuide R&D and protocol development for next-generation aesthetic injectables.Invited Lectures & PublicationsInvited Speaker, Medical Asia 2016“Next-Generation Filler Strategies” presented to 500+ regional aesthetic practitioners.Key Publication:Kim JW, Li MH, Jang JH, et al.15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.Biochem Pharmacol. 2008;76(11):1577–1589.Academic & Professional MembershipsKorean Academy of Laser MedicineWorld Society for Laser Medicine & SurgeryKorean Society for Hair ResearchKorean Society of Anti-Aging DermatologyKorean Society of Obesity & Aesthetic TreatmentKorean Society of Obesity & Body ShapingKorean Society for Stem Cell TherapyKorean Society of Primary CareSelect AchievementsDeveloped research-driven, multi-modal anti-aging protocols integrating lasers, injectables, thread lifts, and stem-cell boosters.Trained 300+ physicians in advanced filler and HIFU applications, elevating national standards of care.Received the Korean Society of Aesthetic Medicine’s Excellence in Education Award.Served as medical advisor on KBS health documentary series and multiple international media features.Core CompetenciesEvidence-Based Protocols: Continuous refinement through outcome analysis of thousands of patient casesIntegrated Anti-Aging: Holistic treatment plans tailored for minimal discomfort and rapid recoveryEducational Leadership: Curriculum design and delivery for clinician workshops and medical symposiaStrategic Consulting: Product development guidance for device manufacturers and biotech firmsLanguages & Continuing EducationLanguages: Korean (native), English (fluent)Continuing Education: Regular faculty at international conferences; numerous peer-reviewed publications in leading dermatology journals. 

Key International PublicationKim JW, Li MH, Jang JH, Na HK, Song NY, Lee C, Johnson JA, Surh YJ.“15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.”Biochemical Pharmacology. 2008 Dec 1;76(11):1577–1589.International Conference PresentationsThe International Meeting of the Society for Free Radical Research–Asia, Nov 6–8, 2003, Seoul, KoreaThe 3rd International Congress of the Asian Society of Toxicology, Feb 1–6, 2003, Bangkok & Chiang Mai, ThailandDomestic Conference PresentationsThe Pharmaceutical Society of Korea Annual Meeting, Oct 10–11, 2003, Seoul, KoreaThe 19th Annual Meeting of the Korean Societies of Toxicology, May 30, 2003, Seoul, KoreaThe 20th Annual Meeting of the Korean Societies of Toxicology, Oct 30, 2003, Seoul, KoreaThe 58th Annual Fall Meeting of the Korean Pediatric Society, Oct 23–24, 2009, Sheraton Walkerhill, Seoul, KoreaThe Annual Fall Meeting of the Korean Academy of Family Medicine, Oct 10–12, 2014, Seoul, Korea

Dr. Kim Min Suk is a highly skilled specialist in laser-based dermatologic and aesthetic treatments. His expertise covers a broad spectrum of advanced technologies, including lifting lasers, energy-based devices, pigmentation lasers, miraDry for excessive sweating, and skin boosters that enhance hydration and radiance. Through detailed and personalized consultations, Dr. Kim carefully assesses each patient’s unique skin condition and aesthetic goals to develop tailored treatment plans. His meticulous attention to detail and sophisticated techniques enable him to effectively improve skin texture, firmness, and glow, helping patients achieve a rejuvenated and youthful appearance with minimal downtime.Education & TrainingGraduated from Daegu Catholic University College of MedicineCompleted residency in Plastic Surgery at Daegu Catholic University HospitalFormer staff physician at Fill-Up Trend Plastic Surgery Professional MembershipsMember of the Korean Society of Plastic and Reconstructive SurgeonsMember of the Korean Wound Management SocietyMember of the Korean Society of Craniofacial Plastic SurgeryDr. Kim’s approach emphasizes personalized care and natural-looking, safe results. He employs sophisticated laser and energy-based techniques, carefully tailored to each patient’s skin type and concerns. His treatments aim to restore skin firmness, improve texture, reduce pigmentation, and enhance overall radiance, all while minimizing downtime for patients.